Take a look at what Questcor says about the group of patients for which this product is for.
They never really said that the product was going to save people with MS.
It is for those which have usually tried known treatment, but had less than stellar results.
Sure this in and of itslef isn't a glowing review for the product, but let's say you have a disease and go through the typical treatment. Unfortunately the treatment doesn't take for you. What do you do at this time? Accept Death?
Now, if the company marketed the product as the best thing in the world for MS patients, than I would totally agree with your assessment of where the stock is headed.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM